BIOXCEL CORPORATION
BioXcel Corporation is a biotechnology firm using big data analytics and machine learning for drug development.
BIOXCEL CORPORATION
Industry:
Artificial Intelligence Biotechnology Life Science Machine Learning
Founded:
2005-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.bioxcel.com
Total Employee:
101+
Status:
Active
Contact:
203 957 2487
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Content Delivery Network Apache Google Apps For Business Cloudflare JS CDN JS
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
CIRECA LLC
Biotechnology AI company imaging by mid-IR radiation developing machine learning models of disease, normal, and immune response in tissue.
ZebiAI
ZebiAI is a platform that applies massive experimental DNA encoded library data sets to power machine learning for drug discovery.
Current Employees Featured
Founder
Official Site Inspections
http://www.bioxcel.com Semrush global rank: 7.6 M Semrush visits lastest month: 454
- Host name: 145.30.62.50.host.secureserver.net
- IP address: 50.62.30.145
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "BioXcel Corporation"
Bioxcel
BioXcel Therapeutics, Inc. is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI, and its approaches.See details»
BioXcel Therapeutics Inc – BioXcel Therapeutics Inc
2 days ago BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders …See details»
BioXcel Corporation - Crunchbase Company Profile & Funding
BioXcel Corporation is a biotechnology firm using big data analytics and machine learning for drug development.See details»
Overview – BioXcel Therapeutics Inc
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. The company’s wholly owned, clinical-stage subsidiary, OnkosXcel Therapeutics, is focused …See details»
BioXcel Therapeutics, Inc. - LinkedIn
BioXcel Therapeutics, Inc. | 9,659 followers on LinkedIn. Developing transformative medicines in neuroscience using artificial intelligence approaches | Biopharmaceutical company developing ...See details»
BioXcel Therapeutics - Crunchbase Company Profile
BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.See details»
BioXcel, LLC - LinkedIn
BioXcel LLC utilizes advanced technologies such as AI (Artificial Intelligence) to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs ...See details»
AI-based Drug Re-innovation – BioXcel Therapeutics Inc
BioXcel Therapeutics is focused on AI-based drug re-innovation in neuroscience. We expedite the discovery and development of new indications for existing late-stage drug candidates and/or approved drugs by leveraging NovareAI: a …See details»
Investor Relations | BioXcel Therapeutics
The Investor Relations website contains information about BioXcel Therapeutics's business for stockholders, potential investors, and financial analysts.See details»
Bioxcel | Home
BioXcel is developing a novel approach to address the high unmet medical need of patients suffering from a rare hematological disorder Diamond Blackfan Anemia. This is a ribosomal …See details»
BioXcel Corporation - Org Chart, Teams, Culture & Jobs | The Org
View BioXcel Corporation's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
BioXcel Therapeutics, Inc. Company Profile | New Haven, CT ...
Find company research, competitor information, contact details & financial data for BioXcel Therapeutics, Inc. of New Haven, CT. Get the latest business insights from Dun & Bradstreet.See details»
BioXcel Corporation Company Profile | Guilford, CT | Competitors ...
Find company research, competitor information, contact details & financial data for BioXcel Corporation of Guilford, CT. Get the latest business insights from Dun & Bradstreet.See details»
BioXcel Therapeutics Provides Clinical and Business Update
Feb 5, 2025 BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. Its wholly owned …See details»
Executive Officers – BioXcel Therapeutics Inc
Dr. Yocca is an accomplished R&D executive and scientist with extensive experience leading global biopharmaceutical companies…See details»
BioXcel Therapeutics - Contacts, Employees, Board Members, …
BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.See details»
BioXcel Therapeutics Company Profile - Office Locations ... - Craft
BioXcel Therapeutics has 3 employees at their 1 location and $1.38 m in annual revenue in FY 2023. See insights on BioXcel Therapeutics including office locations, competitors, revenue, …See details»
BioXcel Company Profile - Office Locations, Competitors ... - Craft
BioXcel has 5 employees across 2 locations. See insights on BioXcel including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
BioXcel Therapeutics Announces 33% Enrollment in SERENITY At …
NEW HAVEN, Conn., March 07, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop …See details»
BioXcel Therapeutics Reports Financial Results for the Fourth …
1 day ago Net Loss : BioXcel Therapeutics had a net loss of $10.9 million for the fourth quarter of 2024, compared to a net loss of $22.3 million for the same period in 2023.See details»